Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

Effective reinduction regimens are needed for children with relapsed and refractory acute myeloid leukemia (AML), as outcomes remain poor. Therapeutic options are limited in this heavily pretreated patient population, many of whom have reached lifetime recommended doses of anthracycline chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramaswamy, Kavitha, Steinherz, Peter G., Agrawal, Anurag K., Forlenza, Christopher J., Mauguen, Audrey, Roshal, Mikhail, Trippett, Tanya, Kernan, Nancy A., Sulis, Maria Luisa, Shukla, Neerav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043926/
https://www.ncbi.nlm.nih.gov/pubmed/35008101
http://dx.doi.org/10.1182/bloodadvances.2021005753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043926/
https://www.ncbi.nlm.nih.gov/pubmed/35008101
http://dx.doi.org/10.1182/bloodadvances.2021005753

Ejemplares similares